The International Society of Atopic Dermatitis (ISAD) and the World Health Organization (WHO) have successfully included urea- and glycerol-based moisturizing creams on the Essential Medicines Lists (EML and EMLc) for treating atopic dermatitis! This is a huge step forward for patient care worldwide, especially in low and middle-income countries (LMICs). By making these creams more […]
Read More
The Enduring Challenge of Atopic Dermatitis Nomenclature: From Hyde to Our Time In 1904, Dr James Nevins HYDE, one of the foremost American dermatologists of his era, published in the Journal of Cutaneous Diseases an editorial titled “The Passing of Eczema.” In it, he lamented the imprecision of dermatologic terminology, declaring that “eczema” had outworn […]
Read More
AI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read More
Abstracts for oral and poster presentations will represent the core of the scientific program at this meeting. Abstracts pertaining to human atopic dermatitis and related fields including animal models are appropriate. Check out your submissions Is your abstract accepted? Please check: …and what to do now? Please sign-in to the Platform and head to the […]
Read More
A One Health Lens on Atopic Dermatitis: Integrating Wastewater Data into a Comprehensive Digital Framework—Is There a Role for Zoonotic Streptococci in AD Flares? The publication by Oh et al. in Water Research (2025) [DOI: 10.1016/j.watres.2025.124012] marks a transformative contribution to environmental dermatology, offering a predictive surveillance model for atopic dermatitis (AD) that is deeply rooted […]
Read MoreAI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read More
We are most saddened by the loss of our esteemed colleague Dr Robert SIDBURY in Chicago this month. Dr SIDBURY was professor in pediatrics and dermatology at the University of Washington School of Medicine, division chief of dermatology at Seattle Children’s Hospital, a co-chair of the recent American Academy of Dermatology Atopic Dermatitis Guidelines, Councillor […]
Read More
Reclaiming Treatment Success in Atopic Dermatitis:Patients Matter Most In the evolving landscape of atopic dermatitis (AD) therapeutics, we are witnessing a striking paradox: never have so many therapies been available, yet patient dissatisfaction remains high. Why? Because the metrics guiding clinical trials and regulatory approvals often diverge sharply from what patients truly value. A rigid […]
Read MoreAI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read More
The ISAD supports GADA’s initiative to collect global epidemiological data using appropriate instruments, which are not always readily available. This real-world data initiative should be encouraged, particularly given the significant information gaps in countries and regions with limited medical infrastructure. If you are interested in participating, please visit https://qualtrics.kcl.ac.uk/ On behalf of the Global Atopic […]
Read More